Rapid, near patient
cardiac Troponin test to
rule in or rule out NSTEMI  

Philips cardiovascular diagnostic tools already provide powerful solutions for the diagnosis and management of heart diseases. In the acute setting, the ECG system identifies life-threatening ST segment elevation myocardial infarction (STEMI). But for most patients with suspicion of ACS and no persistent ST-elevation, you will need to measure cardiac markers, preferably troponin. Yet it can take over an hour to get the results back from the lab. Minicare I-20* acute point-of-care testing reduces this turnaround time.

Philips is developing the Minicare I-20 acute care, in-vitro diagnostics system to give you the clinical information you need, from just a finger prick of blood. Having access to robust, accurate near-patient testing like this makes it possible to measure your patient’s troponin levels while you are assessing them in the emergency department.

This helps you provide patients with the best possible care. You can more quickly identify those who need your urgent attention, helping to reduce their anxiety if a acute cardiac condition is suspected.

With blood test results available in the emergency department within minutes, you will have the confidence to make vital decisions without delay. It may be easier to discharge some patients more quickly, while ensuring others receive early, potentially lifesaving treatment.

Delivering faster results not only benefits your patients. This could make a significant impact on the efficient running of the department. Reducing overcrowding could mean fewer delays in meeting turnaround time targets. And if you are able to increase operational efficiency, then your own stress and that of your team would be less.